Stockreport

ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split

CONTRAVIR PHARMACEUTICALS INC  (CTRV) 
US:NASDAQ Investor Relations: ir.contravir.com/investor-relations
PDF EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercializat [Read more]